Biochemistry, Genetics and Molecular Biology
Estrogen Receptor
46%
P53
32%
Fulvestrant
30%
Protein Complexes
29%
Mediator
29%
Monoglyceride
29%
Mass Spectrometry
29%
Upregulation
29%
Saccharomyces cerevisiae
29%
HDAC1
29%
Minichromosome Maintenance
29%
Angiotensin II Receptor Type 2
29%
Phosphoproteomics
29%
Candidate Gene
29%
Real-Time Polymerase Chain Reaction
29%
Pancreatic Lipase
29%
Triacylglycerol Lipase
29%
Transfection
29%
Protein Kinase B
29%
Programmed Cell Death
29%
Proteome
20%
DNA Microarray
16%
Multigene Family
14%
Nicotinamide Adenine Dinucleotide Phosphate
14%
Gene Product
14%
Expression Analysis
14%
Enzyme
14%
Growth Factor
14%
Morphology
14%
Binding Protein
14%
Signaling Mechanism
11%
Acetylation
11%
Phosphatase
11%
Cancer Cell
11%
Gene Expression
8%
Cell Cycle
6%
Caspase 3
5%
Threonine
5%
G Protein Coupled Receptor
5%
Dephosphorylation
5%
Cell Proliferation
5%
Protein Phosphorylation
5%
Serine
5%
Fluorescence Activated Cell Sorting
5%
Lipocortin
5%
Bioinformatics
5%
Western Blot
5%
Medicine and Dentistry
Hormone Therapy
100%
Breast Cancer
92%
CDK4/6 Inhibitor
91%
Protein Kinase B
59%
Estrogen Receptor Positive Breast Cancer
43%
Cancer Cell
39%
Metastatic Carcinoma
37%
Discriminant Analysis
29%
Cell Line
29%
Predictive Marker
29%
Upregulation
29%
Partial Least Squares Regression
29%
Minichromosome Maintenance Protein 3
29%
Fatty Acid Analysis
29%
Tamoxifen
29%
Genetic Transfection
29%
Fulvestrant
27%
Raman Spectrometry
17%
Cell Cycle
7%
Disease Exacerbation
7%
Cancer Cell Line
5%
Signal-to-Noise Ratio
5%
MDA-MB-435 Cell Line
5%
Gene Expression Profiling
5%
Polyunsaturated Fatty Acid
5%
Proteomics
5%
Biological Marker
5%
Estrogen Receptor
5%
Neoplasm
5%
Pharmacology, Toxicology and Pharmaceutical Science
Endocrine Therapy
89%
Breast Cancer
75%
Estrogen Receptor Positive Breast Cancer
72%
Fulvestrant
39%
Protein P53
32%
Aromatase Inhibitor
29%
Receptor
29%
Aromatase
29%
Angiotensin 2 Receptor
29%
Minichromosome Maintenance Protein 3
29%
Histone Deacetylase 1
29%
Tamoxifen
29%
Protein Kinase B
29%
Biological Marker
25%
Monotherapy
17%
Estrogen Receptor
17%
Neoplasm
16%
Cycline
14%
Disease Exacerbation
10%
Progression Free Survival
9%
Phosphatase
6%
Patient-Derived Organoid
5%
Small Interfering RNA
5%
Primary Tumor
5%
